Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 61.91B | 63.17B | 62.68B | 62.78B | 61.46B | 61.54B |
Gross Profit | 11.28B | 11.39B | 9.93B | 10.12B | 11.65B | 11.42B |
EBITDA | 3.26B | 3.40B | 3.17B | 3.31B | 3.69B | 4.33B |
Net Income | 422.00M | 537.00M | 120.00M | 318.00M | 740.00M | 2.01B |
Balance Sheet | ||||||
Total Assets | 45.95B | 46.34B | 51.56B | 47.13B | 46.90B | 48.06B |
Cash, Cash Equivalents and Short-Term Investments | 4.44B | 4.60B | 3.71B | 2.57B | 2.76B | 7.00B |
Total Debt | 14.84B | 14.71B | 14.55B | 12.22B | 12.34B | 15.12B |
Total Liabilities | 29.44B | 29.92B | 35.91B | 33.93B | 34.44B | 37.18B |
Stockholders Equity | 16.40B | 16.30B | 15.54B | 13.19B | 12.45B | 10.88B |
Cash Flow | ||||||
Free Cash Flow | 705.00M | 933.00M | -438.00M | -204.00M | -1.79B | -161.00M |
Operating Cash Flow | 3.19B | 3.77B | 1.62B | 2.78B | 2.18B | 2.00B |
Investing Cash Flow | -2.47B | -2.83B | -2.53B | -2.98B | -3.92B | -373.00M |
Financing Cash Flow | -52.00M | 24.00M | 1.81B | -116.00M | -2.78B | -4.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $387.07B | 12.04 | 9.59% | 2.05% | 2.58% | -15.95% | |
77 Outperform | €98.78B | 13.20 | 8.63% | 2.46% | -3.92% | -12.29% | |
70 Outperform | ¥127.62B | 22.61 | ― | 1.22% | -5.87% | -35.84% | |
69 Neutral | €237.51B | 20.47 | 15.00% | 2.09% | 9.28% | 8.86% | |
69 Neutral | $655.84B | 19.40 | 10.54% | 1.22% | 12.76% | 162.49% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | €13.22B | 31.31 | 2.69% | ― | -2.68% | 74.69% |